Talk:AVI BioPharma

From Wikipedia, the free encyclopedia

This page is part of WikiProject Oregon, a WikiProject dedicated to articles related to the U.S. state of Oregon.
To participate: join (or just read up) at the project page, or contribute to the project discussion.
PSU stuff & Applegate Trail are the current Collaborations of the week.
Stub This page is rated as Stub-Class on the quality scale.
Low This article is rated as Low-importance on the importance scale.

This is the talk page for discussing improvements to the AVI BioPharma article.

Article policies

Contents

[hide]

[edit] Moved from main article

Not sure if the following belongs in the article. I looked at a few other pharmaceutical company articles and they did not have this sort of info. I'm not an expert on corporate articles so please let me know if I'm wrong. If replaced, the info really needs to be cleaned up and formatted. Katr67 23:19, 21 August 2006 (UTC) Modified by Katr67 19:09, 8 December 2006 (UTC)

[edit] Key Statistics

Market Cap (intraday): 97.65M,Enterprise Value (29-Sep-05)3: 66.79M, Trailing P/E (ttm, intraday): N/A, Forward P/E (fye 31-Dec-06) 1: N/A, PEG Ratio (5 yr expected): N/A, Price/Sales (ttm): 261.09, Price/Book (mrq): 2.56, Enterprise Value/Revenue (ttm)3: 176.10, Enterprise Value/EBITDA (ttm)3: -3.556

[edit] Financial highlights

Fiscal Year Fiscal Year Ends: 31-Dec Most Recent Quarter (mrq): 30-Jun-05 Profitability Profit Margin (ttm): -5413.09% Operating Margin (ttm): -5472.21% Management Effectiveness Return on Assets (ttm): -32.97% Return on Equity (ttm): -55.04% Income Statement Revenue (ttm): 379.25K Revenue Per Share (ttm): 0.01 Qtrly Revenue Growth (yoy): 8.40% Gross Profit (ttm): 969.87K EBITDA (ttm): -18.78M Net Income Avl to Common (ttm): -20.53M Diluted EPS (ttm): -0.52 Qtrly Earnings Growth (yoy): -31.00%

[edit] Balance Sheet

Total Cash (mrq): 32.19M Total Cash Per Share (mrq): 0.728 Total Debt (mrq): 0 Total Debt/Equity (mrq): 0 Current Ratio (mrq): 16.833 Book Value Per Share (mrq): 0.874 Cash Flow Statement From Operations (ttm): -18.15M Free Cashflow (ttm): -12.69M

[edit] Key Executives & Pay Exercised

  • Dr. Denis R. Burger Ph.D., 61

Chairman, Chief Exec. Officer and Member of Exec. Committee $ 450.00K $ 0

  • Mr. Alan P. Timmins , 45

Pres, Chief Operating Officer, Director and Member of Exec. Committee $ 385.00K $ 0

  • Mr. Mark M. Webber , 50

Chief Financial Officer, Principal Accounting Officer, Chief Information Officer and Controller $ 250.00K $ 0

  • Dr. Patrick L. Iversen Ph.D., 49

Sr. VP of R&D $ 300.00K $ 0

  • Dr. Dwight D. Weller Ph.D., 54

Sr. VP of Chemistry and Manufacturing, Director and Member of Exec. Committee $ 250.00K $ 0